Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Champions Oncology, Inc. (NASDAQ: CSBR)
CSBR Stock Predictions and Ratings
WSX Rating:
BUY
WSX Forecast (1yr):
6.50%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
CSBR Stock Analysis
CSBR
PE Ratio:
CSBR
PEG Ratio:
CSBR
Forward EPS Growth (12 month):
-16.70%
CSBR
PS Ratio:
1.4
CSBR
PSG Ratio:
0.1
CSBR
Forward Revenue Growth (12 month):
11.50%
CSBR Articles
No data was found